A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)
Clinical trial NCT02343549 · TERMINATED
Trial details
- NCT number
- NCT02343549
- Sponsor
- Wake Forest University Health Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2020-07-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.